In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Infection and Drug Resistance- New Zealand

doi 10.2147/idr.s175679

Full Text

Abstract

Available in

Date

October 1, 2018

Authors

Publisher

Informa UK Limited

Related search

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

In Vitro Antimicrobial Activity of Ceftolozane/Tazobactam Against P. Aeruginosa and Other Non-Fermenting Gram-Negative Organisms in Adults With Cystic Fibrosis

Journal of Global Antimicrobial Resistance

English

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2016

English

What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?

Expert Review of Anti-Infective Therapy

English

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2018

English

Antimicrobial Susceptibility of Gram-Negative Bacilli Isolated From Intra-Abdominal and Urinary-Tract Infections in Mexico From 2009 to 2015: Results From the Study for Monitoring Antimicrobial Resistance Trends (SMART)

PLoS ONE

Multidisciplinary

2018

English

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Evaluation of Current Activities of Fluoroquinolones Against Gram-Negative Bacilli Using Centralized in Vitro Testing and Electronic Surveillance

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

Amanote Research

In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Infection and Drug Resistance- New Zealand

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

In Vitro Antimicrobial Activity of Ceftolozane/Tazobactam Against P. Aeruginosa and Other Non-Fermenting Gram-Negative Organisms in Adults With Cystic Fibrosis

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Susceptibility of Gram-Negative Bacilli Isolated From Intra-Abdominal and Urinary-Tract Infections in Mexico From 2009 to 2015: Results From the Study for Monitoring Antimicrobial Resistance Trends (SMART)

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

Evaluation of Current Activities of Fluoroquinolones Against Gram-Negative Bacilli Using Centralized in Vitro Testing and Electronic Surveillance

Amanote Research

In Vitro Activity of Ceftazidime&ndash;avibactam, Ceftolozane&ndash;tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Infection and Drug Resistance- New Zealand

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

In Vitro Antimicrobial Activity of Ceftolozane/Tazobactam Against P. Aeruginosa and Other Non-Fermenting Gram-Negative Organisms in Adults With Cystic Fibrosis

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Susceptibility of Gram-Negative Bacilli Isolated From Intra-Abdominal and Urinary-Tract Infections in Mexico From 2009 to 2015: Results From the Study for Monitoring Antimicrobial Resistance Trends (SMART)

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

Evaluation of Current Activities of Fluoroquinolones Against Gram-Negative Bacilli Using Centralized in Vitro Testing and Electronic Surveillance

In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)